National and European patents for domestic cancer drug candidate molecules
Academics from Zonguldak Bülent Ecevit and Istanbul Medipol universities developed new drug candidate molecules effective on breast, prostate and lung cancer cells. The invention is protected by two patents.
· 2 min read

Researchers from Zonguldak Bülent Ecevit University and Istanbul Medipol University developed new drug candidate molecules that could be used in cancer treatment. The study, titled "Synthesis and Investigation of Biological Activities of New Tyrosine Kinase Inhibitors", was carried out by Prof. Dr. Zuhal Gerçek of the Chemistry Department at Zonguldak Bülent Ecevit University's Faculty of Science, Prof. Dr. Mustafa Güzel of Istanbul Medipol University's Faculty of Pharmacy, and researcher Betül Yeşil.
The biological effects of the synthesized molecules on breast, prostate and lung cancer cells were tested in the laboratory. Their effects on different cancer cells were also examined through computer-aided analyses.
A two-stage project
Speaking to reporters, Prof. Dr. Gerçek said the aim of the study was to synthesize molecules that are candidates for cancer drugs and to prove their anticancer activity. She said the project was supported by Scientific Research Projects and consisted of two parts. Explaining that she completed the synthesis of the molecules herself, Gerçek said the second part, the investigation of their anticancer activities, was carried out by Prof. Dr. Mustafa Güzel and Betül Yeşil.
Yaptığımız çalışmalar neticesinde bu yeni moleküllerin özellikle meme, prostat ve akciğer kanseri hücreleri üzerinde etkili olduğunu kanıtlamış olduk. Bu özelliklerini gerek deneysel gerekse teorik olarak ortaya koyduk. Neticesinde bir ulusal, bir de Avrupa patenti olmak üzere iki patentle de bu fikrimizi koruma altına aldık. Böylece yerli ve milli ilaç üretiminde ufak bir adım atmış olduk.
Prof. Dr. Zuhal Gerçek
Background
The invention was registered by the Turkish Patent and Trademark Office in 2024. Its European patent application was also found suitable for registration. The work is thus protected at both the national and European levels.
The new drug candidates are based on a group of molecules known as tyrosine kinase inhibitors. The researchers demonstrated the molecules' effects through both experimental and theoretical methods. These results are seen as a first step for domestic drug development efforts.
Science guides
- What is artificial intelligence and how does it work?Artificial intelligence is a set of methods that let computers perform tasks normally requiring human intelligence, such as learning, pattern recognition, decision-making and language understanding. Most modern systems learn from examples in data.
- What is lodos, why does it occur, and what to do during a lodos warning?Lodos is the everyday Turkish name for a strong southwesterly wind. When a warning is issued, guard against roofs, glass, trees and sea hazards, and follow the Turkish State Meteorological Service (MGM).
- Carbon monoxide poisoning: symptoms and preventionCarbon monoxide (CO) is a colorless, odorless gas produced by incomplete combustion in stoves, water heaters and boilers. If you suspect it, get into fresh air at once and call 112.





Comments
Sign in to comment.